FY2025 · ended Dec 31, 2025 · Revenue $1.99B, +17.2% YoY · Filed Feb 27, 2026
Teleflex Incorporated (TFX) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $2.0 billion and a net loss of $905.6 million. Free cash flow was $1.4 million. As of Jun 30, 2026 it held $326.6 million in cash and investments and $3.0 billion in total debt.
Revenue (TTM)
$2.25B
+110.9% vs year-ago TTM
Net income (TTM)
$-1.03B
-637.5% vs year-ago TTM
Operating cash flow (TTM)
$244.54M
+177.7% vs year-ago TTM
Free cash flow (TTM)
$168.40M
+789.7% vs year-ago TTM
EPS (TTM)
$-23.35
-659.4% vs year-ago TTM
Dividend per share
$1.36
+0.0% vs prior year
Shares outstanding
44.20M
-4.7% vs prior year
Net cash
$-2.66B
as of Jun 30, 2026
Operating margin
2.0%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- TFX (NYSE)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wayne, PA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 96943
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $2.0B | $1.7B | $1.7B | $2.8B | $2.8B |
| Operating income | $118.4M | $103.7M | $258.7M | $499.7M | $628.1M |
| Net income | -$905.6M | $69.7M | $356.3M | $363.1M | $485.4M |
| Diluted EPS | -$20.25 | $1.48 | $7.53 | $7.68 | $10.23 |
| Operating cash flow | $96.7M | $301.9M | $206.1M | $342.8M | $652.1M |
| Free cash flow | $1.4M | $211.4M | $159.7M | $263.6M | $580.5M |
| Total assets | $6.9B | $7.1B | $7.5B | $6.9B | $6.9B |
| Total liabilities | $3.8B | $2.8B | $3.1B | $2.9B | $3.1B |
| Stockholders' equity | $3.1B | $4.3B | $4.4B | $4.0B | $3.8B |
| Cash and investments | $411.4M | $287.4M | $228.2M | $302.1M | $464.3M |
| Total debt | $2.7B | $1.8B | $1.9B | $1.9B | $2.0B |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 9, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Other events
|
Aug 7, 2026 | Aug 7, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 6, 2026 | Aug 6, 2026 |
| 8-K/A | Amended current report | Aug 5, 2026 | Aug 3, 2026 |
| 8-K |
Current report
Acquisition or sale of assets, Regulation FD disclosure
|
Aug 3, 2026 | Aug 3, 2026 |
All 1005 Teleflex Incorporated SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.